Navigation Links
Neurotransmitter That can Yield New Insights in the Fight Against Diabetes Identified

Neuroscientists at the University of Southern California have identified a chemical that can carry the electrical signal that alerts the brain to low blood sugar levels .

The key to the new finding, which is expected to yield new insights in the fight against diabetes, is the neurotransmitter norepinephrine.

According to the researchers, the chemical travels from the hindbrain, which receives warnings of low glucose levels from the body, to the paraventricular hypothalamus, which authorises the consumption of energy stores to replace the missing sugars.

"There's a huge interest in how the body senses glucose," said Alan Watts, director of the Neuroscience Research Institute at USC and a co-author of the study, which has been published in the Journal of Neuroscience.

"How that information is processed by the brain is really a hot current topic," he added.

Arshad Khan, a research assistant professor at the university, says that knowing how neurons relay hypoglycemia warnings is critical to understanding the overall glucose sensing mechanism in the brain.

"That's why I'm interested in this system, because it's very poorly understood," Khan said.

"If we don't know how an automobile's fuel system works to begin with, then how can we expect to fix one when it is not burning fuel appropriately," he added.

During the study, a group of animals were injected with insulin to drop their blood sugar levels, while another group was injected with norepinephrine directly into the paraventricular nucleus.

The researchers then compared brain tissue sections from both groups of animals, and examined their blood samples for the presence of hormones released by paraventricular nucleus activity.

The same paraventricular neurons lit up in both sets of animals, and the animals displayed similar increases in hormone levels, suggesting that norepine phrine plays a role in transmitting the hypoglycemia warning.

"Norepinephrine is capable of activating these signals just like hypoglycemia does," Khan said.

He insists that norepinephrine is not only sufficient but necessary for conveying hypoglycemia signals from the hindbrain.


'"/>




Related medicine news :

1. $1.5 Million Grant to Yale for Narcolepsy-Neurotransmitter Study
2. A Reduction In Calories Found To Yield More Benefits
3. Bone Marrow Cells Could Yield A New Lease of Life
4. Operating on a Beating Heart Yields Better Results For Blocked Heart Arteries
5. Fight the Flab Competition Yields Great Results
6. Exercise Combined with Dialysis Yields Better Results
7. Sleeping Computers Yield Clues About Genetic Disorders
8. Government Accused Of Yielding NHS To Outside Interests
9. Kyphoplasty Yields Good Long-Term Improvement for Spinal Fractures
10. MRI Development Yields Breakthrough in Diagnosis of Liver Fibrosis
11. Cellular Pathway Yields Potential New Weapon in Vaccine Arsenal
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
(Date:10/4/2017)...  South Korean-based healthcare product Development Company I.M. Lab ... Kickstarter. The device will educate the user about ,proper, ... efficiency compared to the dated and pricey CPR training ... of the compression for a more informed CPR training. ... raise $5,000. cprCUBE ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: